Trabecular

Trabecular describes a pattern of tissue made up of small bands, cords, or interconnecting strands called trabeculae. In pathology reports, it refers to how tumor cells are arranged when viewed under the microscope, in this case, in thin cords or bridges rather than sheets, glands, or single cells.

Origin

From the Latin trabecula, meaning "small beam" or "little timber," a diminutive of trabs ("beam"). The term has been used in anatomy since the 19th century to describe beam-like structural elements in tissues such as bone, spleen, and tumors.

Significance in Asbestos Context

For mesothelioma patients, "trabecular" is one of the recognized growth patterns of epithelioid mesothelioma, where tumor cells form narrow cords or ribbons within a fibrous background. Recognizing this pattern matters because epithelioid mesothelioma, including its trabecular variant, generally has a better prognosis and more treatment options than sarcomatoid or biphasic types. The specific pattern noted in a pathology report can also influence which immunohistochemical stains the pathologist uses to confirm mesothelioma and rule out look-alikes such as metastatic adenocarcinoma. In legal claims, the precise histologic subtype and pattern documented in the report help establish the diagnosis your case will rely on.

Example Sentence

The pathology report described an epithelioid mesothelioma with prominent trabecular and tubulopapillary patterns, which her oncologist explained was a more favorable subtype for treatment.

Related Terms

Epithelioid Mesothelioma, Tubulopapillary, Sarcomatoid Mesothelioma, Biphasic Mesothelioma, Immunohistochemistry, Histologic Subtype

Notes

• Ask your oncologist or pathologist to identify the exact histologic subtype and growth pattern (epithelioid, sarcomatoid, biphasic) and any subpatterns noted, such as trabecular, tubulopapillary, or solid. These affect prognosis and treatment planning.
• Request a copy of the full surgical pathology report, not just the summary, and keep it with your medical records; your legal team will need it to document diagnosis.
• Consider asking whether a second pathology review at a mesothelioma specialty center (such as an NCI-designated cancer center) is appropriate, since subtype determination can be difficult and consequential.